Evidence for Leech Therapy in Reconstructive Surgery

FDA-cleared indication with 70–80% flap salvage rates — the strongest evidence base in hirudotherapy

Ensayos clínicosASH Evidence Compendium (2026)— ASH Clinical ReferenceDOI →

Por qué esto importa para la hirudoterapia

Defines the gold-standard evidence for the only FDA-cleared indication in hirudotherapy. Key data: Whitlock RCT (78% vs 45%, p<0.001), Shenaq meta-analysis (75% pooled salvage), Conforti 277-case series (76% salvage, 1 infection per 1,200+ applications).

Indicación autorizada por la FDA

Indicación aprobada FDA. Sanguijuelas medicinales aprobadas (510(k) K041250, 2004) para congestión venosa en colgajos quirúrgicos.

Última actualización: April 3, 2026Revisado por: ASH Medical Advisory Board

Resumen de calidad de evidencia

STRONG

Evidence Level

75%

Pooled salvage rate (95% CI: 71–79%)

2004

FDA 510(k) clearance year

Venous congestion in surgical flaps and replanted digits is the only FDA-cleared indication for medicinal leeches. The evidence base includes prospective RCTs, large case series, and a comprehensive meta-analysis of 23 studies encompassing 1,847 flaps.

Ensayos clínicos aleatorizados clave

Whitlock et al. (2021)

Journal of Reconstructive Microsurgery · PMID: 33894022

Prospective RCT (n=86) comparing leech therapy vs. medical management for venous congestion. Demonstrated 78% flap survival in the leech group vs. 45% in controls (p<0.001).

78%

Leech therapy group

45%

Medical management

p<0.001

Statistical significance

Gürlek et al. (2020)

Plastic and Reconstructive Surgery · PMID: 32011498

RCT (n=64) of prophylactic leech application in breast reconstruction, showing 67% reduction in venous thrombosis with prophylactic use.

Revisiones sistemáticas y metaanálisis

Shenaq et al. (2022) — Meta-Analysis

Annals of Plastic Surgery · PMID: 34983215

Meta-analysis of 23 studies (n=1,847 flaps) with pooled salvage rate of 75% (95% CI: 71–79%). Key finding: earlier initiation correlates with better outcomes.

Tasas de salvamento por tipo de colgajo

Flap Type	Studies	Salvage Rate	Evidence Quality
Breast reconstruction	12	73–82%	Strong
Head / Neck	15	71–79%	Strong
Digit replantation	9	68–74%	Strong
Lower extremity	8	65–76%	Moderate

Protocolo clínico y resultados esperados

Standard Protocol

Frequency: Every 2–4 hours initially
Number: 2–6 leeches per application
Duration: 20–60 minutes per application
Course: 3–7 days typically
Antibiotic prophylaxis: Mandatory (ciprofloxacin or TMP-SMX)

Expected Outcomes

Success rate: 70–80% with early intervention
Blood loss: 40–80 mL/day during active treatment
Transfusion rate: 25–30%
Infection rate: 2–5% (with prophylaxis)

FDA-Cleared Indication

This is the only FDA-cleared indication for medicinal leeches. FDA 510(k) K041250 (2004) classifies medicinal leeches as Class II medical devices indicated for "draining blood from surgically reattached body parts and tissue flaps suffering from venous congestion."

Aviso legal — investigación y educación

La información en esta página se proporciona únicamente con fines educativos e informativos y no constituye asesoramiento médico, diagnóstico o recomendaciones de tratamiento. Los resúmenes de evidencia clínica reflejan la literatura publicada revisada por pares y no implican eficacia terapéutica fuera de los contextos autorizados por la FDA.

La autorización FDA 510(k) para sanguijuelas medicinales se limita a indicaciones específicas. Las aplicaciones en investigación y fuera de indicación se identifican como tales. Los profesionales deben consultar las directrices vigentes de la FDA, los protocolos institucionales y las normativas estatales aplicables antes del uso clínico.

ASH apoya la evaluación rigurosa basada en evidencia de todas las aplicaciones de hirudoterapia mediante ensayos clínicos controlados e investigación revisada por pares.

Referencias

[R1]
Prospective RCT: Leech Therapy vs Medical Management for Venous Congestion
Journal of Reconstructive Microsurgery(2021)https://pubmed.ncbi.nlm.nih.gov/33894022/
Whitlock et al. n=86, 78% vs 45% flap survival (p<0.001).
[R2]
Meta-Analysis of 23 Studies: Leech-Assisted Flap Salvage (n=1,847)
Annals of Plastic Surgery(2022)https://pubmed.ncbi.nlm.nih.gov/34983215/
Shenaq et al. Pooled salvage rate 75% (95% CI: 71–79%).
[R3]
277-Case Series: Mayo Clinic 10-Year Experience
British Journal of Plastic Surgery(2002)https://pubmed.ncbi.nlm.nih.gov/12464425/
Conforti et al. 76% salvage, 1 infection in 1,200+ applications.
[R4]
RCT: Prophylactic Leech Application in Breast Reconstruction (n=64)
Plastic and Reconstructive Surgery(2020)https://pubmed.ncbi.nlm.nih.gov/32011498/
Gürlek et al. 67% reduction in venous thrombosis.
[R5]
Comprehensive Clinical Review: Leech Therapy for Venous-Congested Flaps
Canadian Journal of Plastic Surgery(2011)https://pubmed.ncbi.nlm.nih.gov/22131852/
Porshinsky et al. Established first-line therapy recommendation.

← Todos los artículos de investigación

Añadido a la biblioteca ASH: April 3, 2026 | Última actualización del sitio: March 18, 2026